JAFRAL Phage Summit 2026 Announces Keynote Speaker: Dr. Christian Grøndahl of SNIPR Biome

Opening Day 2: Clinical Trials & Current Results

‍

To ensure a strong and purposeful flow of the conference content, Dr. Grøndahl will open Day 2, which is dedicated to Clinical Trials & Current Results. His keynote will focus on real‑world clinical evidence and translational advancements in bacteriophage‑based therapies — offering attendees a clear understanding of how groundbreaking scientific concepts are progressing toward clinical application.

This session will provide valuable insight into how phage therapy is evolving from laboratory innovation into practical therapeutic solutions addressing some of today’s most urgent medical challenges.

‍

About Dr. Christian Grøndahl

‍

Dr. Grøndahl is an internationally recognized biotechnology leader with more than 30 years of experience. He holds multiple doctoral degrees, an MBA, and is the co‑inventor of several foundational CRISPR patents. Throughout his distinguished career, he has received multiple scientific and entrepreneurial awards that acknowledge his significant contributions to biotech innovation, clinical translation, and therapeutic development.

As Co‑founder and CEO of SNIPR Biome, he is at the forefront of advancing precision microbiome engineering and CRISPR‑armed bacteriophage therapies.

‍

Keynote Session Highlight

‍

Title: “Developing CRISPR‑armed phages (CAPs) for treating multi‑drug resistant infections”

In this keynote, Dr. Grøndahl will explore one of the most transformative areas in the fight against antimicrobial resistance. His talk will address the urgent global need for new therapeutic strategies and will shed light on how CRISPR‑enhanced bacteriophages may become a powerful tool against multi‑drug resistant pathogens.

‍

‍